Radotinib
Product Specifications
Target
Apoptosis|||STAT|||JAK|||Bcr-Abl
Related Pathways
Stem Cells|||Angiogenesis|||JAK/STAT signaling|||Cytoskeletal Signaling|||Tyrosine Kinase/Adaptors|||Chromatin/Epigenetic|||Apoptosis
Purity
0.9997
Bioactivity
Radotinib (IY-5511), and sometimes referred to by its investigational name IY5511, is a drug for the treatment of different types of Y, most notably Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) with resistance or intolerance of other tyrosine kinase Bcr-Abl inhibitors
Smiles
Cc1cn(cn1)-c1cc(NC(=O)c2ccc(C)c(Nc3nccc(n3)-c3cnccn3)c2)cc(c1)C(F)(F)F
Molecular Formula
C27H21F3N8O
Molecular Weight
530.5
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Product Datasheet
https://www.targetmol.com/attachment/DataSheet/C95DF10F-0E8F-49B9-AE90-DA133448260B/T2328
CAS Number
926037-48-1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6164456-01 0.1 mL
SRF (Serum Response Factor (c-fos Serum Response Element-Binding Transcription Factor), MCM1) (AP)
Ask
View Details 
MBS6164456-02 5x 0.1 mL
SRF (Serum Response Factor (c-fos Serum Response Element-Binding Transcription Factor), MCM1) (AP)
Ask
View Details 
MBS2079311-01 0.1 mL
APC/CY7-Linked Polyclonal Antibody to Sepiapterin Reductase (SPR)
Ask
View Details